Exclusive Worldwide Rights to Ocular Product to prevent Sight-Destroying Endophthalmitis Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Asset Purch.

  • Financing Rounds
  • 1

Exclusive Worldwide Rights to Ocular Product to prevent Sight-Destroying Endophthalmitis General Information

Description

Ocular product used to prevent various eye infections. The product is used to treat Endophthalmitis using various ocular procedures.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Buildings and Property
Other Industries
Diagnostic Equipment
Surgical Devices
Acquirer
Primary Office
  • 4400 Biscayne Boulevard
  • Miami, FL 33137
  • United States
+1 (305) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Exclusive Worldwide Rights to Ocular Product to prevent Sight-Destroying Endophthalmitis Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Exclusive Worldwide Rights to Ocular Product to prevent Sight-Destroying Endophthalmitis‘s full profile, request access.

Request a free trial